Search Results 51-60 of 16251 for monoclonal antibody
Trastuzumab is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of normal ...
It helps the immune system destroy cancer cells. Rituximab injection is a monoclonal antibody. Rituximab injection is used together with other medicines (eg, ...
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some find cancer cells and help kill them or carry cancer- ...
Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find ...
The Antibody Hybridoma Core generates monoclonal or polyclonal antibodies for researchers to use in their laboratories or research programs and for clinicians ...
Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. ... At least 6 weeks since prior monoclonal antibody therapy; At least 7 ...
Eculizumab injection is a monoclonal antibody that works on the immune system. This medicine is available only under a restricted distribution program called ...
It is a monoclonal antibody. Tocilizumab injection is also used alone or together with glucocorticoids (steroid medicine) to treat giant cell arteritis ...
The newly approved treatments are three monoclonal antibodies: ... Rituximab, a monoclonal antibody often used to treat NMOSD , costs about $18,000 a year.
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies · Overview · Participation eligibility.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Their crucial work saves lives every day. Let Mayo Clinic researchers know they’re appreciated with a quick message.